Italy employs further GMO delay tactics

Article Abstract:

The ministers from several member countries, led by Italy, demanded to establish new rules for the coexistence of organic and GM agriculture before Genetically modified organism (GMO) approvals can resume. The European commission is already formulating a strategy to manage coexistence, suggesting that Italy is simply using the issue of GM thresholds for organic products as another delaying tactic.

Europe, Legal issues & crime, Government regulation, Basic Chemical Manufacturing, Legal/Government Regulation, Industrial Organic Chemicals, Organic Chemicals, Laws, regulations and rules, European Union. European Commission, Genetically modified organisms, Organic compounds

---

Italian biotech too reliant on big pharma

Article Abstract:

A Rome-based religious group, Congregation of the sons of the immaculate conception (CSIC) that owns a network of hospitals and that markets dermatological products, bought Pfizer's Italian R&D center in Nerviano, near Milan, for an undisclosed amount in 14 May 2004. According to Francesco Sinigaglia, CEO of BioXell, the quality of biotech companies is more important than quality.

Product development, Forecasts, trends, outlooks, Product quality, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Drugs, Dermatological Preparations, Skin Treatment Preparations, Analysis, Biotechnology industry, Pharmaceutical industry, Biotechnology industries, Forecasts and trends, Quality management, Beliefs, opinions and attitudes, Market trend/market analysis, Pfizer Inc., PFE, Dermatologic agents, Sinigaglia, Francesco, BioXell SpA

---

Green ag minister wreaks havoc on Italy's agbiotech

Article Abstract:

Italy's Green minister for agriculture and forestry, Alfonso Pecoraro Scanio, is stressing Italian agbiotech research to the point of collapse. The official is limiting the efforts of scientists and stifling research by attaching strict conditions to public funding.

Agricultural Chemicals, Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing

Similar abstracts:

• Abstracts: EU attempts to streamline biotech "vision". French loan arranger seeks biotech posse. Biosafety rules get thumbs up
• Abstracts: In at the deep end. Stocks to watch
• Abstracts: The price to pay for protection from the market. Biotech builds castles in the air. The rise of the biotech
• Abstracts: It's good to talk about telecoms. BT calls time on debts. Telecoms in the fast lane
• Abstracts: Pre-launch look at Sky. Sunny side up. The Sky's the limit

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.